User:Mr. Ibrahem/Lenacapavir

Lenacapavir, sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. It is used together with other medications, in those with medication resistant disease. It is started by mouth and than given by injection under the skin twice per year.

Common side effects include reactions at the injection site and nausea. Other side effects may include immune reconstitution syndrome. While there is no evidence of harm in pregnacy, such use has not been well studied. It is a capsid inhibitors and works by interfering with multiple steps of the viral lifecycle.

Lenacapavir was approved for medical use in Europe, Canada, and the United States in 2022. In the United States it costs about 42,250 USD the first year and 39,000 USD each year thereafter as of 2022.